NEW YORK (GenomeWeb News) – Bayer CropScience said today it has inked two agreements with Cellectis plant sciences that extend a partnership focused on modifying and editing plant genes and genomes to improve crops.

Under the agreements, the partners will use tools Cellectis developed to create commercial traits for the canola seed market, and Bayer will have access to Cellectis' technologies for gene stacking and targeted mutagenesis that enable it to engineer plant genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.